Vaxcyte
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $14,446 | $0 |
Gross Profit | -3,478 | -3,091 | 11,498 | -2,480 |
EBITDA | -149,503 | -108,915 | -118,728 | -113,026 |
EBIT | -152,981 | -112,006 | -121,676 | -115,506 |
Net Income | -128,703 | -95,020 | -180,801 | -92,664 |
Net Change In Cash | 0 | 0 | 14,446 | 0 |
Free Cash Flow | -166,768 | -171,196 | -185,879 | -64,887 |
Cash | 518,669 | 611,512 | 397,451 | 545,134 |
Basic Shares | 117,256 | 111,690 | 95,364 | 101,668 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -10,171 | -9,196 | -1,800 | -1,405 |
EBITDA | -382,870 | -189,778 | -98,284 | -86,859 |
EBIT | -393,041 | -198,974 | -100,084 | -88,264 |
Net Income | -402,266 | -239,640 | -100,084 | -87,819 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -315,905 | 327,137 | ||
Free Cash Flow | -364,667 | -176,445 | -127,948 | -47,783 |
Cash | 397,451 | 834,657 | 68,985 | 386,200 |
Basic Shares | 97,157 | 64,877 | 51,922 | 51,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.10 |
2024-03-31 | -$0.85 |
2023-12-31 | -$1.82 |
2023-09-30 | -$0.91 |
